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Summary
Retinitis pigmentosa (RP) is the most common inherited
retinal dystrophy, with extensive allelic and nonallelic
genetic heterogeneity. Autosomal recessive RP (arRP) is
the most common form of RP worldwide, with at least
nine loci known and accountable for ∼10%–15% of all
cases. Gamma-aminobutyric acid (GABA) is the major
inhibitory transmitter in the CNS. Different GABA re-
ceptors are expressed in all retinal layers, and inhibition
mediated by GABA receptors in the human retina could
be related to RP. We have selected chromosomal regions
containing genes that encode the different subunits of
the GABA receptors, for homozygosity mapping in in-
bred families affected by arRP. We identify a new locus
for arRP, on chromosome 6, between markers D6S257
and D6S1644. Our data suggest that 10%–20% of
Spanish families affected by typical arRP could have
linkage to this new locus. This region contains subunits
GABRR1 and GABRR2 of the GABA-C receptor, which
is the effector of lateral inhibition at the retina.
Introduction
Retinitis pigmentosa (MIM 268000) is the most com-
mon retinal dystrophy. The classic findings are nycta-
lopia, visual-field constriction, “bone spicula” pigmen-
tation, attenuated retinal vessels, waxy pallor of the
optic disk, and no results detectable by electroretino-
gram (Jime´nez-Sierra et al. 1989).
RP presents important locus and allelic heterogeneity,
with different modes of inheritance: autosomal domi-
Received November 10, 1997; accepted for publication March 24,
1998; electronically published April 24, 1998.
Address for correspondence and reprints: Dr. G. Antin˜olo, Unidad
de Gene´tica Me´dica y Diagno´stico Prenatal, Hospital Universitario
“Virgen del Rocı´o,” Avenida de Manuel Siurot s/n, 41013 Sevilla,
Spain. E-mail: gantinolo@hvr.sas.cica.es
 1998 by The American Society of Human Genetics. All rights reserved.
0002-9297/98/6206-0023$02.00
nant and recessive, X-linked, and digenic. Whether clas-
sic linkage analysis or the molecular study of candidate
genes is used, the number of loci related to this group
of disease genes continues to grow (Dryja and Li 1995).
Autosomal recessive RP (arRP) is the most common
form of RP worldwide. In Spain, 47% of cases of the
disease present autosomal recessive inheritance (C.
Ayuso, personal communication). To date, nine loci re-
lated to arRP have been identified (Rosenfeld et al. 1992;
McLaughlin et al. 1993; Knowles et al. 1994; van Soest
et al. 1994; Dryja et al. 1995; Huang et al. 1995; Gu
et al. 1997; Martı´nez-Mir et al. 1997; Maw et al. 1997
[MIM numbers for the loci identified by these studies
are 180380, 180072, 600132, 600105, 123825,
180071, 180069, 601718, and 180090, respectively]).
These loci account for only 10%–15% of all cases of
arRP (Dryja et al. 1995).
The genes that form the biochemical machinery in-
volved in photoreception have been, until recently, the
mainstay of studies concerning the etiology of arRP
(Dryja 1990). Toxicity mediated by excitatory neuro-
transmitters such as glutamate or aspartate is, however,
a well-established concept in other neurological and neu-
rodegenerative disorders (Lipton and Rosenberg 1994).
We must remember that the rod is the first neuron of
the visual pathway, establishing a glutamanergic syn-
apsis with a rod bipolar cell, at the spherule, in the outer
plexiform layer (Rapaport 1989). This synapsis is si-
multaneously modulated by different inhibitory efferents
of horizontal cell axons and interplexiform cells (Kolb
1974). These cells contain gamma-aminobutyric acid
(GABA), the principal inhibitory neurotransmitter of the
CNS (Sivilotti and Nistri 1991). GABA activates spe-
cific receptors, which are classified into three sub-
types—GABAa, GABAb, and GABAc—according to the
mechanism of action and pharmacological properties
(Bormann and Feigenspan 1995). It is believed that the
GABAergic efferents that reach the outer plexiform layer
of the retina act as feedback of the visual pathway and
seem to be the effectors of lateral inhibition (Kolb 1994).
We propose for RP a pathogenic mechanism that is
consistent with the Lisman and Fain’s (1995) hypothesis
of the equivalence of light. In our model, the lack of
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targets (GABAergic receptors), at the spherule, for
GABA provokes an abnormal release of glutamate from
the synaptic vesicles of the rod, precipitating a cytotoxic
effect on the adjacent tissue. This cytotoxicity is anal-
ogous to the degeneration that ensues when a dying ex-
citatory neuron releases its neurotransmitter contents
into surrounding tissue (Tanaka et al. 1997).
To explore this model further, we used homozygosity
mapping (Lander and Botstein 1987) to analyze con-
sanguineous families affected by arRP. For candidate
chromosomal regions, we selected loci that contain genes
encoding the different subunits of the GABA receptors.
The aim of this study was to determine whether inhi-
bition mediated by GABA receptors in the retina could
be related to RP. The genes that encode the different
subunits of these receptors are usually grouped into clus-
ters throughout the genome: GABRR1 and GABRR2,
on 6q (Cutting et al. 1992); GABRA5, GABRB3, and
GABRG3, on 15q;GABRA2, GABRB1, GABRA4, and
GABRG1, on 4p; and GABRA1, GABRA6, GABRB2,
and GABRG2, on 5q (Schantz Wilcox et al. 1992).
The location of these genes in the human transcript
map (Schuler et al. 1996), together with the density of
the genetic map available at present (Dib et al. 1996),
permits both the selection of highly polymorphic short
tandem-repeat (STR) markers linked to these clusters
and the homozygosity analysis of consanguineous fam-
ilies affected by arRP.
With this strategy, we obtained linkage to the 6q clus-
ter in a subgroup of families affected by arRP. This re-
gion contains the rho1 and rho2 subunits of the GABAc
receptor (Cutting et al. 1991, 1992). Both subunits are
expressed in the retina and form part of the GABAc
receptor that is expected to mediate the lateral inhibition
of the light responses in the vertebrate retina (Bormann
and Feigenspan 1995). The physiological roles of GA-
BAc receptors on horizontal cells have yet to be deter-
mined, although GABAc receptors may mediate regen-
erative responses in horizontal cells, since many
horizontal cells that are GABAergic are also sensitive to
GABA (Lukasiewicz 1996). In addition, excitatory syn-
aptic transmission between bipolar cells and ganglion
cells could be modulated by GABAc-receptor activation
(Lukasiewicz 1996).
Subjects and Methods
Subjects
We selected 17 unrelated families or index patients.
All of the index patients were the offspring of consan-
guineous marriages (table 1) and had typical RP symp-
toms, characteristic fundus examination, and nothing
detectable by scotopic electroretinogram. Autosomal re-
cessive inheritance was confirmed by the existence of
two or more affected members of one family and/or the
presence of first- or second-degree consanguinity among
the parents, as were a complete lack of signs and symp-
toms in the parents of the patients.
Once we obtained evidence of linkage to the selected
candidate region, 12 nuclear and noninbred families af-
fected by arRP (with two or more affected members and
the same clinical and electroretinographic criteria) were
added to the study, to allow us to perform a linkage
analysis with markers of the critical region (table 1).
Selection and Analysis of Markers of the Candidate
Region in Families Affected by arRP
According to the Human Transcript Map (Schuler et
al. 1996), the GABRR1 gene is located on the long arm
of chromosome 6, in a 5-cM region between D6S445
and D6S1644. The gene GABRR2 has been located, on
the same map, between D6S1601 and D6S1570. This
location overlaps partially with that assigned to gene
GABRR1. The minimum candidate region that contains
both genes is of 7.2 cM and is found between D6S445
and D6S1570.
To perform the screening of this region in inbred pa-
tients, we selected five highly polymorphic markers in
the candidate region. The initial analysis was performed
with the following map: D6S445 (.70)–0.6
cM–D6S1609 (.81)–0.8 cM–D6S1627 (.80)–3.9
cM–D6S1613 (.91)–1.9 cM–D6S1570 (.78) (the het-
erozygosity of each marker is shown in parentheses, and
the distance between two contiguous markers on the
map is also shown). Information concerning the markers
used was extracted from the Ge´ne´thon public database
and also from Genome Database (GDB).
Individuals homozygous for three or more contiguous
markers were reevaluated, along with the rest of the
available family, in order to allow us to perform a link-
age analysis and to calculate the multipoint LOD scores,
using the fixed map described above and running Map-
maker/Homoz software (Kruglyak et al. 1995). The al-
lelic frequencies of the markers used in this analysis were
obtained from GDB, except for markers D6S1613 and
D6S1627, for which the data derived from the families
studied was used. Since the allelic frequency critically
affects the multipoint analysis (Gschwend et al. 1996),
all the allelic frequencies !.1 were overestimated up to
a frequency of .1. For this reason, the multipoint LOD-
score values obtained by Mapmaker/Homoz are
conservative.
Once linkage was established, 12 nuclear noninbred
families affected by arRP underwent linkage analysis,
with markers D6S402, D6S1627, and D6S1613. Our
objective was to identify new families linked to this re-
gion (extension analysis). Those families that were either
not informative or semi-informative in relation to
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Table 1
Analysis of Linkage to the GABA-C Cluster at 6q in 29 Spanish Families Affected by arRP
arRP Familya Consanguinityb
No. of Affected Sibs/
No. of Healthy Sibs
No. of Par-
ents Avail-
able for
Genotyping
Status of GABA-C
Cluster Markerc
Inbred:
RP5 1st 3/1 2 Homozygosity
RP23 2d 2/1 2 Heterozygosity
RP29 2d 2/0 2 Heterozygosity
RP65 1st 1/0 0 Heterozygosity
RP66 1st 2/0 1 Heterozygosity
RP77 1st 1/0 0 Heterozygosity
RP92 1st 1/0 0 Heterozygosity
RP95 2d 1/3 2 Heterozygosity
RP99 1st 2/1 1 Heterozygosity
RP108 2d 1/2 1 Heterozygosity
RP167 2d 1/0 0 Homozygosity
RP190 1st 2/3 1 Heterozygosity
RP193 1st 1/2 2 Heterozygosity
RP206 1st 1/0 2 Heterozygosity
RP216 1st 1/3 2 Heterozygosity
RP217 2d 1/2 2 Heterozygosity
RP260 2d 1/0 0 Heterozygosity
Noninbred:
RP1 NA 2/3 1 (/)
RP19 NA 3/3 2 (/)
RP31 NA 3/2 2 (/.73)
RP42 NA 2/3 2 (/)
RP73 NA 3/0 1 (.89/.37)
RP76 NA 3/1 2 (/)
RP116 NA 2/1 1 (/.06)
RP156 NA 2/1 2 (/)
RP176 NA 2/2 1 (/)
RP178 NA 2/1 0 (.73/)
RP203 NA 2/0 2 (/)
RP214 NA 2/7 1 (1.48/1.48)
a Underlining denotes families with positive linkage to the new locus (see fig. 1).
b NA  not applicable.
c The markers used for inbred families were D6S445, D6S1609, D6S1627, D6S1613 and
D6S1570; and the markers used for noninbred families wereD6S402, D6S1627 andD6S1613.
The heterozygosity in inbred families is considered to be a criterion for exclusion of a locus
(Lander and Botstein 1987). Data in parentheses for the noninbred families are two-point LOD
scores at v  .0 for D6S402 and D6S1627, respectively.
D6S402, D6S1627, or D6S1613 were analyzed with
flanking markers. For extension analysis, the LOD
scores were calculated by use of the MLINK program
from the LINKAGE package. Those families with pos-
itive LOD scores were reevaluated with 17 markers from
the pericentromeric region of chromosome 6 (see below).
The 29 families affected by arRP that were available
underwent a homogeneity test with program HOMOG
v3.35, with use of the results of the two-point LOD score
obtained for markers D6S402 and D6S1627.
Determination of the Critical Region
and Multipoint LOD Scores
All the recessive inbred and noninbred families (RP5,
RP73, RP167, and RP214) that presented linkage with
the markers of the critical region were reevaluated, in-
creasing the marker density of this interval, in order to
allow us to perform a multipoint analysis of the region
and to determine the minimum region that contains the
new gene. For this study, we selected 12 new markers
located in this chromosomal region (see fig. 1). The de-
termination of the multipoint LOD score was performed
with the Mapmaker/Homoz program (Kruglyak et al.
1995), by application of the information found in fam-
ilies RP5, RP73, RP167, and RP214. The allelic fre-
quencies and thresholds of the markers used in this anal-
ysis were selected as described above. The estimated
frequency of the mutated allele was .00125.
DNA Genotyping
The extraction of high-molecular-weight genomic
DNA from peripheral blood of the patients and related
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Figure 1 Haplotypes of families that present linkage to the new locus of arRP on 6q. The underlined markers correspond to those used
in the initial screening of the region (see Subjects and Methods section).
family members was performed according to standard
procedures (Dracapoli et al. 1994). The polymorphic
markers (i.e., STRs) were genotyped individually by
PCR. The primer pairs of the selected markers were gen-
erated in an oligonucleotide synthesizer (Oligo 1000
DNA synthesizer; Beckman). One of the oligonucleo-
tides from each pair was 5′ labeled during synthesis with
Cy5-amidyte fluorochrome (Pharmacia Biotech). All the
PCR reactions were performed with 100 ng of genomic
DNA, in a final volume of 10 ml. Each reaction contained
200 mMof each dNTP (BoehringerMannheim), 10 pmol
of each primer, 1 # PCR buffer Mg (Boehringer
Mannheim), and 1 unit of Taq DNA polymerase (Boeh-
ringer Mannheim). The PCR was performed with an
initial denaturation of 5 min at 94C, followed by 35
cycles of 1 min at 94C, 1 min at 52–60C (depending
on the primer pair), and 1 min at 72C; and the final
extension was 7 min at 72C. A total of 1–3 ml of each
product of PCR was mixed (v/v) with loading buffer
(100% deionized formamide and 10 mg of dextran blue/
ml). The samples were denatured for 3 min at 95C and
were loaded onto a 0.5-mm 6% polyacrylamide gel with
7 M urea and 0.6# Tris-borate EDTA. Electrophoresis
was performed in the Alf-Express automatic sequencer
(Pharmacia Biotech), at 250 V and 50C. The sizes of
the alleles obtained were determined by the Fragment
Manager program (Pharmacia Biotech), by use of a stan-
dard-size fluorescent marker (Cy5 syzer, 50–500 bp;
Pharmacia Biotech).
Results
In the initial screening of the candidate region on 6q,
2 of the 17 inbred patients affected by arRP (patients
RP5.II-1 and RP167.II-8), although unrelated, showed
homozygosity for all the markers selected from this re-
gion (see fig. 1 and table 1). The former of these two
patients, RP5.II-1, is the offspring of a first-cousin mar-
riage (consanguinity coefficient F  ). Both parents,116
two affected siblings, and a healthy child were all avail-
able for a linkage analysis. In the linkage analysis per-
formed on family RP5, a recombination phenomenon
can be observed between markers D6S1601 and
D6S1644 in patient RP5.II-2. All the markers between
D6S1650 and D6S1601 are homozygous by descent in
the affected patients, whereas the healthy individual ap-
pears to be a noncarrier (see fig. 1).
Only two members of family RP167 were available
for genotyping. As can be seen in figure 1, patient II-8
is the child of a second-cousin marriage (F  ). In this164
case, the region of homozygosity in RP167.II-8 includes
all the markers between D6S402 and D6S1570, which
overlaps with the region of homozygosity identified for
family RP5. Besides, the other available affectedmember
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of the family (individual RP167. II-3, cousin of the pa-
tient) has inherited, between markers D6S402 and
D6S1601, the same chromosome region from their
mother as has been inherited by the index patient
(RP167. II-8).
It is worth pointing out that all the affected members
of both inbred families (RP5 and RP167) share the same
alleles at D6S1627, D6S1595, and D6S1601 (7/7, 3/3
and 2/2, respectively), which could suggest linkage dis-
equilibrium. All markers are found in the region that,
according to the human transcript map (Schuler et al.
1996), contains the GABRR1 gene.
The combined information from both families defines
a minimum critical region of 16.1 cM between D6S257
and D6S1644, situating the new gene for arRP on the
long arm of chromosome 6.
The LOD scores in these families were calculated by
use of a map with five fixed polymorphic markers, by
use of Mapmaker/Homoz software (see Subjects and
Methods section). We obtained multipoint LOD-score
values of 2.16 at 0.5 cM, for family RP5, and 0.96 at
1 cM, for family RP167. The combined multipoint LOD
score for both families is 3.1037 at 0.6 cM of the fixed
map (near D6S1629).
Once linkage was established for the markers of our
candidate region, we performed an extension analysis.
We added to the study a total of 12 new, unrelated, and
noninbred families affected by arRP. These 12 families
were analyzed by use of markers linked to the critical
region (table 1). Again, we obtained positive LOD scores
for two new families (RP73, LOD score 1.18 at recom-
bination fraction [v]  .0, in D6S1596; and RP214,
LOD score 1.48 at v  .0, in D6S1627) (fig. 1). The
homogeneity tests for markers D6S402 and D6S1627,
performed in 29 families affected by arRP, gave the fol-
lowing results: LOD score calculated under the assump-
tion of locus heterogeneity (hLOD) 5.0151 at v  .0
and a  .18, for D6S402; and hLOD 1.6748 at v  .0
and a  .13, for D6S1627. Notwithstanding the small
sample available, the value forD6S402 is consistentwith
linkage. Also, in family RP73, the paternal chromosome
inherited by the three affected siblings shares the same
haplotype, for markers D6S1595 and D6S1601, that is
present in the two inbred families (RP5 and RP167) (see
fig. 1).
With the combined information from families RP5,
RP73, RP167, and RP214, we performed an additional
multipoint analysis of the critical region, including 34
cM of the pericentromeric region of chromosome 6, us-
ing 17 polymorphic markers (mean heterozygosity .77).
Using the Mapmaker/Homoz software, we obtained a
maximum multipoint LOD score of 5.43 in 28 cM of
the fixed map, close to D6S1627 (fig. 2).
Discussion
The extensive nonallelic heterogeneity found in in-
herited disorders such as nonsyndromic deafness or RP
is, no doubt, the greatest obstacle to finding the loci
responsible for these diseases (Strachan and Read 1996).
In arRP, ∼80% of the pedigrees do not appear to be
linked to any of the nine loci identified thus far (Dryja
et al. 1995). In spite of this, the allele-sharing methods,
such as homozygosity mapping, make possible, with rel-
atively scarce samples, the identification of new loci.
With homozygosity mapping, three completely infor-
mative inbred individuals would be sufficient to achieve
a LOD score 13 (Farrall 1993). The informativeness of
families RP5 and RP167 is enough to obtain linkage.
On the other hand, the data proceeding from haplotype
and extension analysis suggest that this new locus could
explain 10%–20% of the cases of arRP in Spain, since
we have found linkage in 4/29 (13.7%) families affected
by arRP, and since the values of the homogeneity tests
for marker D6S402 are found to be within the range of
linkage. We do not yet know whether these results can
be confirmed in other populations. In this case, the ex-
periment would have to be applied by other study groups
to families with typical arRP.
This is the third gene identified, in relation to RP, on
chromosome 6. According to the human transcription
map, the new locus appears 14.4 cM below the RDS/
peripherin gene (responsible for forms of autosomal
dominant RP, digenic RP, and certain forms of macular
degeneration [MIM 179605]) and 26 cM below RP14
(an arRP locus located at 6p21) (Knowles et al. 1994).
Another three loci exist that are related to eye diseases
and that colocalize on 6q: two for maculopathies (MIM
136550 and 600110) on 6q11-6q16.2 (Small et al. 1992;
Stone et al. 1994) and one for progressive bilateral cho-
rioretinal atrophy (MIM 600790), which partially over-
laps with the other two (Kelsell et al. 1995). More distal
is the locus for oculodentodigital syndrome (MIM
164200), on 6q22-q24 (Gladwin et al. 1997). The seven
loci on 6p21-6q24 that are related to eye diseases con-
firm the great richness of retinal-specific transcripts in
this region of the genome (Small et al. 1992).
The results of our study show the power of the com-
bination of the Human Transcript Map with the genetic
map developed by Ge´ne´thon. By selection of a group of
genes specific for the retina and with only five markers
(in the initial screening), linkage was obtained. We be-
lieve that the development of tissue-specific transcription
maps will permit the design of screening strategies that
are even more powerful.
The results of our study and others (Fukai et al. 1996;
Pastural et al. 1997) support the approach of screening
regions of the genome that contain candidate genes (the
indirect candidate-gene approach), prior to a systematic
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Figure 2 Multipoint analysis of the families showing linkage (RP5, RP73, RP167, and RP214) in a region of 34 cM between markers
D6S1582 andD6S1570. Sex-averaged genetic distances (in cM) between the markers are given (Dib et al. 1996). The centromere of chromosome
6 is located between D6S257 and D6S402. The underlined markers correspond to those used in the initial screening of the region (see Subjects
and Methods section).
search throughout the totality of the genome (genome-
wide screening) (Inglehearn 1997), mainly because of the
cost/benefit ratio of the projects. This would be the case
for diseases with genetic heterogeneity, where a great
number of nuclear families and a high density of markers
(spaced every 5 cM) would be necessary in order to allow
us to obtain linkage through genomewide screening
(Gschwend et al. 1996).
The GABA receptors contained in this region are our
first candidates for mutation analysis. This chromosomal
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region was selected because it contained GABRR1 and
GABRR2, the genes of expression in the retina. If any
member of this cluster—GABRR1, GABRR2, or any
other subunit not yet characterized—finally presentsmu-
tations, there would be important implications for the
future design of search strategies for RP genes, since
GABA receptors are a superfamily of genes (DeLorey
and Olsen 1992), and since other, related gene clusters
could be involved with RP. Some are being studied by
our group at present.
GABRR1 and GABRR2 represent attractive candi-
date genes within the critical region that we have defined
for arRP. However, we note that their involvement in
the disease remains to be demonstrated and that a large
number of expressed dequence tags also map to this
interval. If further genetic and physiological studies con-
firm that GABAergic modulation is involved in retinal
degeneration, other functions and genes at the level of
the first synapsis would be RP candidates, aside from
the phototransduction cascade and retinal vitamin-A
metabolism (Dryja 1990; Gu et al. 1997; Maw et al.
1997).
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